United Kingdom· GB-APID-41117111000001109
Welireg 40mg tablets
A belzutifan product containing belzutifan, registered in United Kingdom by Merck Sharp & Dohme (UK) Ltd. The same ATC class is registered in 14 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Belzutifan is registered in 14 of 19 countries.
Countries holding a registration under ATC L01XX74 (belzutifan), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Belzutifan · ATC L01XX74
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of belzutifan costs, country by country.
Normalised to the WHO defined daily dose (0.12 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Belzutifan · price per daily dose (0.12 g)
USD · FX 28 Sept 2026
- FR France$0.54
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Belzutifan
- Manufacturer
- Merck Sharp & Dohme (UK) Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01XX74
- ATC class
- Belzutifan
- Defined daily dose
- 0.12 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin00191778023817
- gtin0191778023817
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Belzutifan in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaWELIREGMERCK CANADA INC
- SwitzerlandWelireg 40 mg, FilmtablettenMSD Merck Sharp & Dohme AG
- United StatesWELIREGMerck Sharp & Dohme LLC
- CzechiaWELIREGMerck Sharp & Dohme B.V., Haarlem
- SpainWELIREG 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULAMerck Sharp & Dohme B.V.
- FinlandWELIREGMerck Sharp & Dohme B.V.
- BelgiumWelireg 40 mgMerck Sharp & Dohme
- IrelandWELIREG 40 mg film-coated tabletsMerck Sharp & Dohme BV,
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Welireg
- Liechtenstein · Welireg
- Norway · Welireg
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/472788b9-3d3e-48ef-9e7e-c20763f8487a GET /v1/drugs/472788b9-3d3e-48ef-9e7e-c20763f8487a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "41117111000001109",
"desc": "Welireg 40mg tablets (Merck Sharp & Dohme (UK) Ltd)",
"form": "Oral tablet",
"vpid": "41140911000001102",
"source": "dmd",
"vtm_id": "41135811000001100",
"strength": "40 mg",
"substance": "Belzutifan",
"ingredient": "Belzutifan",
"supplier_code": "39306911000001106"
}See everything about belzutifan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.